Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825716 | Clinical Therapeutics | 2013 | 12 Pages |
Abstract
After MI, early treatment with licensed n-3 fatty acids was associated with improvement in all-cause mortality in patients with and without type 2 diabetes, against a background of contemporary cardiovascular risk-modifying treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Chris D. PhD, Julian P. MD, Sara MSc, Emma S.M. PhD, Mathias G. MD, Kausik K. MD, MPhil, Craig J. PhD,